DJIA 17,191.37 -195.84 -1.13%
NASDAQ 4,637.99 -43.50 -0.93%
S&P 500 2,002.16 -27.39 -1.35%
market minute promo

Antares Pharma, Inc. (NASDAQ: ATRS)

2.27 -0.08 (-3.40%)

REAL-TIME: Last trade at

Extended Hours: $2.27 $0.00 (0.00%)
Quote as of (NASDAQ)



company name or ticker

Recent Quotes

ATRS $2.27 -3.40%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $2.36
Previous Close $2.35
Daily Range $2.26 - $2.37
52-Week Range $1.82 - $4.96
Market Cap $298.9M
P/E Ratio -10.22
Dividend (Yield) $0.00 (0.0%)
Volume 942,251
Average Daily Volume 1,040,341
Current FY EPS -$0.23

Sector

Healthcare

Industry

Healthcare Information Services

Antares Pharma, Inc. (ATRS) Description

The Company develops, produces and markets pharmaceutical delivery products, including transdermal gels, oral fast melting tablets and reusable needle-free and disposable mini-needle injector systems. Website: http://www.antarespharma.com/

News & Commentary

3 Stocks Crushed by the Market This Week

Find out which health-care stocks got beaten down the most by the market over the past few days.

Will Patterson Companies' Safety Measures Hold? - Analyst Blog

Health Care Sector Update for 01/13/2015: ARIAD, ATRS, CTIC, CLTX

Henry Schein Expands Dental Line in North America, Stock Up - Analyst Blog

Interesting ATRS Put Options For August 2015

Short Interest In Antares Pharma Decreases By 11%

Generic EpiPen Could Give These 2 Stocks A Jolt Of Adrenaline

Analyzing Antares Pharma Q3 2014 Earnings

Antares Pharma's (ATRS) CEO Eamonn Hobbs on Q3 2014 Results -- Earnings Call Transcript

Update: Antares Pharma Looks To Improve Intellectual Property

Comparative Analysis Reveals Undervalued Asset In Antares' Pipeline: First And Only Testosterone Aut

Comparative Analysis Reveals Undervalued Asset In Antares' Pipeline: First And Only Testosterone Auto-Injector

See More ATRS News...

ATRS's Top Competitors

ATRS $2.27 (-3.40%)
Current stock: ATRS
MDT $73.41 (-2.46%)
Current stock: MDT
BAX $70.16 (-0.71%)
Current stock: BAX
$0.00 (0.00%)
Current stock: